Genprex

$0.90
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-3.23%) As of 3:00 PM EDT today
-$0.03 (-3.23%) Today

Why Robinhood?

You can buy or sell Genprex and other stocks, options, ETFs, and crypto commission-free!

About GNPX

Genprex, Inc. Common Stock, also called Genprex, is a clinical stage gene therapy company, which engages in the development of novel proprietary technology platform for the treatment of cancer. Read More It develops the Oncoprex immunogene therapy which targets the non-small cell lung cancer and other solid tumors. The company was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.

Employees
7
Headquarters
Austin, Texas
Founded
2009
Market Cap
14.73M
Price-Earnings Ratio
Dividend Yield
Average Volume
91.02K
High Today
$0.95
Low Today
$0.8915
Open Price
$0.94
Volume
21.76K
52 Week High
$2.50
52 Week Low
$0.641

Collections

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.